BAT publishes science update featuring Vuse vaping brand and latest news on Tobacco Harm Reduction – Retail Times



BAT has today published its latest Science Update, which is a special edition focusing on Vuse – the leading global vaping brand – and our recently completed innovative cross-sectional study.

BAT strongly believes that generating robust, relevant and accessible scientific research is important to continue building consumer understanding and confidence in alternative tobacco and nicotine products.  Despite the growing evidence and support from public health bodies for alternative tobacco and nicotine products, many consumers are still not aware that these products are a better alternative than smoking. 

The most recent Science Update focuses on the Vuse cross-sectional study, which is designed to assess and provide insights into the real-world health impact of vaping.  The study compares measures for certain biomarkers of potential harm from Vuse consumers  who have been using the product for over six months with the results from smokers, former smokers and never smokers.  BAT’s study will provide further important data for the growing evidence base for the reduced-risk# potential of Vuse, and the full set of findings are due to be published later this year.

Dr Sharon Goodall, BAT’s head of regulatory science, said: “Our consumers want information that is easy-to-understand, accessible and reliable.  To deliver this we must start with research and generate data that can then be shared with regulators, public health bodies and consumers.  We believe that the innovative and ground-breaking research we are doing across our portfolio plays a critical role in creating understanding and confidence.  This is why our regular Science Updates are so important.”

By investing in science and innovation, BAT is accelerating its delivery of A Better Tomorrow.


Tagged





Source link

BAT has today published its latest Science Update, which is a special edition focusing on Vuse – the leading global vaping brand – and our recently completed innovative cross-sectional study. BAT strongly believes that generating robust, relevant and accessible scientific research is important to continue building consumer understanding and confidence in alternative tobacco and nicotine…